US Chemical Giant Abandons 'Toxic Cocktail' Herbicide Amid Decade-Long Litigation
Corteva, a leading US chemical giant, has announced it will stop producing Enlist Duo, a highly contentious herbicide containing a toxic mix of Agent Orange and glyphosate. The move comes after years of intense public pressure and litigation, with environmental groups celebrating the decision as a major victory.
The herbicide was widely criticized due to its proven links to cancer, ecological damage, and human health issues. Both Agent Orange and glyphosate have been linked to serious adverse effects, including cancer, birth defects, and respiratory problems. The US Environmental Protection Agency (EPA) has faced criticism for approving the product despite these risks.
The EPA initially approved Enlist Duo in 2014 but was later invalidated by a federal court in 2020 due to concerns over its safety and environmental impact. However, the agency reapproved it in 2022, sparking further controversy. Environmental groups argued that the revised approval process did not adequately address the herbicide's risks.
The decision to discontinue Enlist Duo marks a significant shift for Corteva, which had reported sales of over $1 billion in Enlist products last year. The company has not explained why it decided to pull the product from the market, but environmental advocates say it is a welcome relief.
"This toxic cocktail was never meant to be used on food crops," said Kristina Sinclair, a staff attorney with the Center for Food Safety. "We're celebrating this as a win, and our food system will never again be doused in such a toxic substance."
However, the decision does not bring an end to all litigation related to Enlist Duo. A separate lawsuit seeks to invalidate the EPA's approval of another Enlist product containing 2,4-D, which is also considered a carcinogen.
The move highlights concerns over the EPA's pesticide approval process and its prioritization of getting products to market quickly. Environmental groups argue that this approach can lead to flawed assessments of safety and environmental impact, with devastating consequences for human health and the environment.
"The EPA always looks for 'tweaks' rather than fundamentally rethinking their approach," said Nathan Donley, environmental health director with the Center for Biological Diversity. "This decision is a step in the right direction, but it's only the beginning of a broader conversation about the need for meaningful reforms to our pesticide approval process."
Corteva, a leading US chemical giant, has announced it will stop producing Enlist Duo, a highly contentious herbicide containing a toxic mix of Agent Orange and glyphosate. The move comes after years of intense public pressure and litigation, with environmental groups celebrating the decision as a major victory.
The herbicide was widely criticized due to its proven links to cancer, ecological damage, and human health issues. Both Agent Orange and glyphosate have been linked to serious adverse effects, including cancer, birth defects, and respiratory problems. The US Environmental Protection Agency (EPA) has faced criticism for approving the product despite these risks.
The EPA initially approved Enlist Duo in 2014 but was later invalidated by a federal court in 2020 due to concerns over its safety and environmental impact. However, the agency reapproved it in 2022, sparking further controversy. Environmental groups argued that the revised approval process did not adequately address the herbicide's risks.
The decision to discontinue Enlist Duo marks a significant shift for Corteva, which had reported sales of over $1 billion in Enlist products last year. The company has not explained why it decided to pull the product from the market, but environmental advocates say it is a welcome relief.
"This toxic cocktail was never meant to be used on food crops," said Kristina Sinclair, a staff attorney with the Center for Food Safety. "We're celebrating this as a win, and our food system will never again be doused in such a toxic substance."
However, the decision does not bring an end to all litigation related to Enlist Duo. A separate lawsuit seeks to invalidate the EPA's approval of another Enlist product containing 2,4-D, which is also considered a carcinogen.
The move highlights concerns over the EPA's pesticide approval process and its prioritization of getting products to market quickly. Environmental groups argue that this approach can lead to flawed assessments of safety and environmental impact, with devastating consequences for human health and the environment.
"The EPA always looks for 'tweaks' rather than fundamentally rethinking their approach," said Nathan Donley, environmental health director with the Center for Biological Diversity. "This decision is a step in the right direction, but it's only the beginning of a broader conversation about the need for meaningful reforms to our pesticide approval process."